Type 1 and type 2 diabetes technology
and medications have come a long way since the invention of insulin in 1921.But day-to-day management still requires countless finger pricks to draw blood and measure glucose levels.
FreeStyle Libre Flash Glucose Monitoring System, manufactured by Abbott Diabetes Care Inc. and officially approved on September 27 by the
U.S. Food and Drug Administration (FDA), strives to be a true game-changer for people with diabetes.Unlike the
Dexcom or
Medtronic’s Guardian and Enlite continuous glucose monitors (CGM), which require a minimum of twice-daily finger pricks to calibrate the CGM’s readings with that of a traditional blood glucometer, the Libre system requires zero calibration.The technology is still similar in that the Libre also uses a small sensor wire that a patient inserts into their subcutaneous tissue.
